A case series describing the use of argatroban in patients on extracorporeal circulation

ASAIO Journal

Volumn 53, Issue 4, 2007, Pages 460-463

  Cornell, Timothy ^a   Wyrick, Polly ^b   Fleming, Geoffrey ^a   Pasko, Deborah ^a,c,d   Han, Yong ^a   Custer, Joseph ^a   Haft, Jonathan ^b,e   Annich, Gail ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d Section of Orthopaedic Surgery   (United States)

^e UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COAGULATION; ENZYME INHIBITION; PATIENT MONITORING; PROTEINS;

ARGATROBAN; EXTRACORPOREAL LIFE SUPPORT; HEPARIN ANTICOAGULATION; THROMBOCYTOPENIA;

MEDICAL PROBLEMS;

ARGATROBAN; HEPARIN; THROMBIN INHIBITOR;

ADOLESCENT; ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; CONTROLLED STUDY; EXTRACORPOREAL CIRCULATION; FEMALE; HUMAN; LONG TERM CARE; MALE; THROMBOCYTOPENIA; TREATMENT DURATION;

ADULT; AGED; ANTICOAGULANTS; CARDIAC OUTPUT, LOW; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EXTRACORPOREAL CIRCULATION; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PIPECOLIC ACIDS; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; THROMBIN; THROMBOCYTOPENIA; TREATMENT OUTCOME; WHOLE BLOOD COAGULATION TIME;

EID: 34547655499     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e31805c0d6c     Document Type: Article

References (17)

1. Dyke PC II, Russo P, Mureebe L, Russo J, Tobias JD: Argatroban for anticoagulation during cardiopulmonary bypass in an infant. Paediatr Anaesth 15: 328-333, 2005.
2. Edwards JT, Hamby JK, Worrall NK: Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient. Ann Thorac Surg 75: 1622-1624, 2003.
3. Furukawa K, Ohteki H, Hirahara K, Narita Y, Koga S: The use of argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operations. J Thorac Cardiovasc Surg 122: 1255-1256, 2001.
4. Johnston N, Wait M, Huber L: Argatroban in adult extracorporeal membrane oxygenation. J Extra Corpor Technol 34: 281-284, 2002.
5. Kawada T, Okada Y, Hoson M, et al: Argatroban, an attractive anticoagulant, for left heart bypass with centrifugal pump for repair of traumatic aortic rupture. Jpn J Thorac Cardiovasc Surg 47: 104-109, 1999.
6. Lubenow N, Selleng S, Wollert HG, Eichler P, Mullejans B, Greinacher A: Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use. Ann Thorac Surg 75: 577-579, 2003.
7. Malherbe S, Tsui BC, Stobart K, Koller J: Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VII. Anesthesiology 100: 443-445, 2004.
8. Mejak B, Giacomuzzi C, Heller E, et al: Argatroban usage for anticoagulation for ECMO on a post-cardiac patient with heparin-induced thrombocytopenia. J Extra Corpor Technol 36: 178-181, 2004.
9. Scott LK, Grier LR, Conrad SA: Heparin-induced thrombocytopenia in a pediatric patient receiving extracorporeal support and treated with argatroban. Pediatr Crit Care Med 7: 473-475, 2006.
10. Sakai M, Ohteki H, Narita Y, Naitoh K, Natsuaki M, Itoh T: Argatroban as a potential anticoagulant in cardiopulmonary bypass-studies in a dog model. Cardiovasc Surg 7: 187-194, 1999.
11. Young G, Yonekawa KE, Nakagawa P, Nugent DJ: Argatroban as an alternative to heparin in extracorporeal membrane oxygenation circuits. Perfusion 19: 283-288, 2004.
12. Swaniker F, Kolla S, Moler F, et al: Extracorporeal life support outcome for 128 pediatric patients with respiratory failure. J Pediatr Surg 35: 197-202, 2000.
13. Thiele H, Lauer B, Hambrecht R, Boudriot E, Cohen HA, Schuler G: Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 104: 917-2922, 2001.
14. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310, 1986.
15. Arepally GM, Ortel TL: Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med 355: 809-817, 2006.
16. van Wyk V, Badenhorst PN, Luus HG, Kotze HF: A comparison between the use of recombinant hirudin and heparin during hemodialysis. Kidney Int 48: 1338-1343, 1995.
17. Deitcher SR, Topoulos AP, Bartholomew JR, Kichuk-Chrisant MR: Lepirudin anticoagulation for heparin-induced thrombocytopenia. J Pediatr 140: 264-266, 2002.